Allergen-specific immune deviation from a T(H)2 to a T(H)1 response induced by dendritic cells and collagen type I

Journal of Allergy and Clinical Immunology

Volumn 104, Issue 5, 1999, Pages 1052-1059

  Brand, Udo ^a   Bellinghausen, Iris ^a   Enk, Alexander H ^a   Jonuleit, Helmut ^a   Becker, Detlef ^a   Knop, Jürgen ^a   Saloga, Joachim ^a,b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Collagen type I; Dendritic cells; T cell differentiation

Indexed keywords

COLLAGEN TYPE 1; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 5;

ARTICLE; ATOPY; CELL ACTIVATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; HELPER CELL; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL;

EID: 0032714863     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(99)70088-6     Document Type: Article

References (28)

1. 1. Kay AB, Ying S, Varney V, Gaga M, Durham SR, Moqbel R, et al. Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colons-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J Exp Med 1991;173:775-8.
2. 2. Wierenga BA, Snoek M, de Groot C, Chretien I, Bos JD, Jansen HM, et al. Evidence for compartmentalization of functional subsets of CD2+ T lymphocytes in atopic patients. J Immunol 1990;144:4651-6.
3. 3. Vercelli D. Regulation of IgE synthesis. Allergy Proc 1993;14:413-6.
4. 4. Lundgren M, Persson U, Larsson P, Magnusson C, Smith CI, Hammarstrom L, et al. Interleukin 4 induces synthesis of IgE and IgG4 in human B cells. Eur J Immunol 1989;19:1311-5.
5. 5. Ishizaka T, Conrad DH, Schulman ES, Sterk AR, Ko CG, Ishizaka K. IgE-mediated triggering signals for mediator release from human mast cells and basophils. Fed Proc 1984;43:2840-5.
6. 6. Sanderson CJ. Interleukin-5, eosinophils, and disease. Blood 1992;79:3101-9.
7. 7. Ferrante A, Mocatta F, Goh DH. Changes in IgG and IgE antibody levels to bee venom during immunotherapy. Int Arch Allergy Appl Immunol 1986;81:284-7.
8. 8. Jutel M, Piehler WJ, Skrbie D, Urwyler A, Dahinden C, Muller UR. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures. J Immunol 1995;154:4187-94.
9. 9. McHugh SM, Deighton J, Stewart AG, Lachmann PJ, Ewan PW. Bee venom immunotherapy induces a shift in cytokine responses from a TH-2 to a TH-1 dominant pattern: comparison of rush and conventional immunotherapy. Clin Exp Allergy 1995;25:828-38.
10. 10. Bellinghausen I, Metz G, Enk AH, Christmann S, Knop J, Saloga J. Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects. Eur J Immunol 1997;27:1131-9.
11. 11. Inaba K, Metlay JP, Crowley MT, Steinman RM. Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J Exp Med 1990;172:631-40.
12. 12. Levin D, Constant S, Pasqualini T, Flavell R, Bottomly K. Role of dendritic cells in the priming of CD4+ T lymphocytes to peptide antigen in vivo. J Immunol 1993;151:6742-50.
13. 13. Sornasse T, Flamand V, De Becker G, Bazin H, Tielemans F, Thielemans K. et al. Antigen-pulsed dendritic cells can efficiently induce an antibody response in vivo. J Exp Med 1992;175:15-21.
14. 14. Heufler C, Koch F, Stanzl U, Topar G, Wysocka M, Trinchieri G. et al. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur J Immunol 1996;26:659-68.
15. 15. Villacres Eriksson M. Antigen presentation by naive macrophages, dendritic cells and B cells to primed T lymphocytes and their cytokine production following exposure to immunostimulating complexes. Clin Exp Immunol 1995;102:46-52.
16. 16. Schuler G, Brang D, Romani N. Production and properties of large numbers of dendritic cells from human blood. Adv Exp Med Biol 1995;378:43-52.
17. 17. Sallusto F Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus inlerleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994;179:1109-18.
18. 18. Jonuleit H, Kuhn U, Muller G, Steinbrink K, Paragnik L, Schmitt E, et al. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 1997;27:3135-42.
19. 19. Nestle FO, Alijagic S, Gilliet M, Sun Y, Grabbe S, Dummer R, et al. Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells. Nat Med 1998;4:328-32.
20. 20. Julius MH, Simpson E, Herzenberg LA. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol 1973;3:645-9.
21. 21. Jacobs DM, Morrison DC. Inhibition of the mitogenic response to lipopolysaccharide (LPS) in mouse spleen cells by polymyxin B. J Immunol 1977;118:21-7.
22. 22. Kalinski P, Hilkens CM, Snijders A, Snijdewint FG, Kapsenberg ML. Dendritic cells, obtained from peripheral blood precursors in the presence of PGE2, promote Th2 responses. Adv Exp Med Biol 1997;417:363-7.
23. 23. Brand U, Bellinghausen I, Enk AH, Jonuleit H, Becker D, Knop J, et al. Influence of extracellular matrix proteins on the development of cultured human dendritic cells. Eur J Immunol 1998;28:1673-80.
24. 24. Suri RM, Austyn JM. Bacterial lipopolysaccharide contamination of commercial collagen preparations my mediate dendritic cell maturation in culture. J Immunol Methods 1998;214:149-63.
25. 25. de Saint Vis B. Fugier Vivier I, Massacrier C, Gaillard C, Vanbervliet B, Ait Yahia S, et al. The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation. J Immunol 1998;160:1666-76.
26. 26. Cella M, Scheidegger D, Palmer Lehmann K, Lane P, Lanzavecchia A, Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 1996;184:747-52.
27. 27. Sornasse T, Larenas PV, Davis KA, de Vries JE, Yssel H. Differentiation and stability of T helper 1 and 2 cells derived from naive human neonatal CD4+ T cells, analyzed at the single-cell level. J Exp Med 1996;184:473-83.
28. 28. Tschoetschel U, Schwing J, Frosch S, Schmitt E, Schuppan D, Reske Kunz AB. Modulation of proliferation and lymphokine secretion of murine CD4+ T cells and cloned Th1 cells by proteins of the extracellular matrix. Int Immunol 1997;9:147-59.